Prostate Biopsy Patterns in the CaPSURE Database: Evolution With Time and Impact on Outcome After Prostatectomy

Journal of Urology

Volumn 179, Issue 1, 2008, Pages 136-140

  Shah, Jay B ^a   McKiernan, James M ^a   Elkin, Eric P ^a   Carroll, Peter R ^a   Meng, Maxwell V ^a  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

biopsy; outcome assessment (health care); prostate; prostatectomy; prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DATABASES, FACTUAL; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGISTRIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 36849073718     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.08.126     Document Type: Article

References (12)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer Statistics, 2005. CA Cancer J Clin 55 (2005) 10
2. Presti Jr. J.C., Chang J.J., Bhargava V., and Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 163 (2000) 163
3. Meng M.V., Elkin E.P., DuChane J., and Carroll P.R. Impact of increased number of biopsies on the risk of the identified prostate cancer. J Urol 176 (2006) 63
4. Cooperberg M.R., Pasta D.J., Elkin E.P., Litwin M.S., Latini D.M., Du Chane J., et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 173 (2005) 1938
5. Mitchell R.E., Shah J.B., Olsson C.A., Benson M.C., and McKiernan J.M. Does year of radical prostatectomy independently predict outcome in prostate cancer?. Urology 67 (2006) 368
6. Lubeck D.P., Litwin M.S., Henning J.M., Stier D.M., Mazonson P., Fisk R., et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 48 (1996) 773
7. Cooperberg M.R., Broering J.M., Litwin M.S., Lubeck D.P., Mehta S.S., Henning J.M., et al. The contemporary management of prostate cancer in the United States: lessons from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), a national disease registry. J Urol 171 (2004) 1393
8. Hodge K.K., McNeal J.E., Terris M.K., and Stamey T.A. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142 (1989) 71
9. Babaian R.J., Toi A., Kamoi K., Troncoso P., Sweet J., Evans R., et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 163 (2000) 152
10. Emiliozzi P., Maymone S., Paterno A., Scarpone P., Amini M., Prioetti, et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy. J Urol 172 (2004) 2224
11. Master V.A., Chi T., Simko J.P., Weinberg V., and Carroll P.R. Independent impact of extended-pattern biopsy on prostate cancer stage migration. J Urol 174 (2005) 1789
12. Freedland S.J., Terris M.K., Csathy G.S., Kane C.J., Kane C.J., Amling C.L., et al. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. J Urol 171 (2004) 2215